Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Jazz Pharmaceuticals Inc (JAZZ)  
$109.27 0.37 (0.34%) as of 4:30 Thu 4/18


Download
   
Exchange: Nasdaq National Market
Security Type: N/A
Shares Out: 61,150,000
Market Cap: 6.68(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $113.49 - $145.93
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Jazz Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious diseases with limited or no options. Co.'s primary marketed products are: Xyrem® (sodium oxybate) oral solution, for the treatment of both cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Xywav™ (calcium, magnesium, potassium, and sodium oxybates) oral solution, for the treatment of cataplexy or EDS in narcolepsy patients seven years of age and older; and Sunosi® (solriamfetol), to improve wakefulness in adult patients with EDS associated with narcolepsy or obstructive sleep apnea.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 12,000 12,000 12,000 12,000
Total Buy Value $1,435,800 $1,435,800 $1,435,800 $1,435,800
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 8,704 9,538 26,327 202,744
Total Sell Value $986,699 $1,086,171 $3,399,099 $29,455,215
Total People Sold 2 4 12 19
Total Sell Transactions 3 5 21 74
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 1250
  Page 17 of 50  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Miller Michael Patrick EVP, US Commercial   •       –      –    2019-02-28 4 A $0.00 $0 D/D 8,400 32,503     -
   Young Matthew P. EVP & CFO   •       –      –    2019-02-27 4 AS $137.91 $121,912 D/D (884) 27,967     -
   Hooper Suzanne Sawochka EVP & General Counsel   •       –      –    2019-02-27 4 AS $140.00 $933,240 D/D (6,666) 39,738     -
   Hooper Suzanne Sawochka EVP & General Counsel   •       –      –    2019-02-27 4 OE $46.83 $312,169 D/D 6,666 46,404     -
   Miller Michael Patrick EVP, US Commercial   •       –      –    2019-02-26 4 D $127.76 $52,893 D/D (414) 24,103     -
   Wilson Karen J SVP, Finance & PAO   •       –      –    2019-02-26 4 D $127.76 $29,385 D/D (230) 15,463     -
   Mcgill Iain SVP, Europe & Rest of World   •       –      –    2019-02-26 4 D $127.76 $50,337 D/D (394) 21,105     -
   Young Matthew P. EVP & CFO   •       –      –    2019-02-26 4 D $127.76 $132,104 D/D (1,034) 28,851     -
   Young Matthew P. EVP & CFO   •       –      –    2019-02-26 4 AS $125.93 $129,960 D/D (1,032) 29,885     -
   Hooper Suzanne Sawochka EVP & General Counsel   •       –      –    2019-02-26 4 D $127.76 $84,705 D/D (663) 39,738     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2019-02-26 4 D $127.76 $436,939 D/D (3,420) 271,589     -
   Miller Michael Patrick EVP, US Commercial   •       –      –    2019-02-25 4 D $126.25 $66,660 D/D (528) 24,517     -
   Wilson Karen J SVP, Finance & PAO   •       –      –    2019-02-25 4 D $126.25 $39,138 D/D (310) 15,693     -
   Mcgill Iain SVP, Europe & Rest of World   •       –      –    2019-02-25 4 D $126.25 $69,311 D/D (549) 21,499     -
   Young Matthew P. EVP & CFO   •       –      –    2019-02-25 4 D $126.25 $153,773 D/D (1,218) 30,917     -
   Hooper Suzanne Sawochka EVP & General Counsel   •       –      –    2019-02-25 4 D $126.25 $98,854 D/D (783) 40,401     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2019-02-25 4 D $126.25 $338,224 D/D (2,679) 275,009     -
   Swisher Daniel N Jr President and COO   •       –      –    2019-01-03 4 D $126.01 $202,120 D/D (1,604) 16,512     -
   Hooper Suzanne Sawochka EVP & General Counsel   •       –      –    2018-12-14 4 AS $140.21 $467,460 D/D (3,334) 41,184     -
   Hooper Suzanne Sawochka EVP & General Counsel   •       –      –    2018-12-14 4 OE $46.83 $154,305 D/D 3,295 44,518     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2018-12-03 4 AS $151.78 $151,780 D/D (1,000) 277,688     -
   Young Matthew P. EVP & CFO   •       –      –    2018-11-23 4 AS $150.00 $105,000 D/D (700) 32,068     -
   Mulligan Seamus Director   –       •      –    2018-11-15 4 B $141.86 $7,228,001 D/D 50,000 1,100,868 2.39     -
   Miller Michael Patrick EVP, US Commercial   •       –      –    2018-11-13 4 AS $149.27 $29,854 D/D (200) 24,972     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2018-11-01 4 AS $159.45 $207,290 D/D (1,300) 278,615     -
  1250 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 17 of 50
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us